药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Benzonatate
Fendiline
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Fendiline.
Benzonatate
Bedaquiline
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Bedaquiline.
Benzonatate
Antazoline
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Antazoline.
Benzonatate
Telavancin
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Telavancin.
Benzonatate
Tucidinostat
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Tucidinostat.
Benzonatate
Tedisamil
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Tedisamil.
Benzonatate
Pracinostat
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Pracinostat.
Benzonatate
Lofexidine
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Lofexidine.
Benzonatate
Fluspirilene
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Fluspirilene.
Benzonatate
Prenylamine
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Prenylamine.
Benzonatate
Terlipressin
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Terlipressin.
Benzonatate
Aceprometazine
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Aceprometazine.
Benzonatate
Probucol
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Probucol.
Benzonatate
Papaverine
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Papaverine.
Benzonatate
Dimenhydrinate
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Dimenhydrinate.
Benzonatate
Mesoridazine
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Mesoridazine.
Benzonatate
Levosimendan
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Levosimendan.
Benzonatate
Thiosalicylic acid
Thiosalicylic acid may increase the hypoglycemic activities of Sunitinib.
Benzonatate
Choline salicylate
Choline salicylate may increase the hypoglycemic activities of Sunitinib.
Benzonatate
Carbaspirin calcium
Carbaspirin calcium may increase the hypoglycemic activities of Sunitinib.